nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—CYP3A4—Temozolomide—malignant glioma	0.191	1	CbGbCtD
Ipratropium bromide—Disorder sight—Temozolomide—malignant glioma	0.0237	0.0416	CcSEcCtD
Ipratropium bromide—Lung disorder—Temozolomide—malignant glioma	0.0159	0.028	CcSEcCtD
Ipratropium bromide—Influenza-like symptoms—Temozolomide—malignant glioma	0.0158	0.0277	CcSEcCtD
Ipratropium bromide—Methylphenidate—SLC6A3—malignant glioma	0.0127	0.5	CrCbGaD
Ipratropium bromide—Dexmethylphenidate—SLC6A3—malignant glioma	0.0127	0.5	CrCbGaD
Ipratropium bromide—Influenza like illness—Temozolomide—malignant glioma	0.011	0.0192	CcSEcCtD
Ipratropium bromide—Abnormal vision—Carmustine—malignant glioma	0.0102	0.0179	CcSEcCtD
Ipratropium bromide—Abnormal vision—Temozolomide—malignant glioma	0.00984	0.0173	CcSEcCtD
Ipratropium bromide—Swelling—Carmustine—malignant glioma	0.00961	0.0168	CcSEcCtD
Ipratropium bromide—Eye pain—Carmustine—malignant glioma	0.00939	0.0165	CcSEcCtD
Ipratropium bromide—Eye pain—Temozolomide—malignant glioma	0.00907	0.0159	CcSEcCtD
Ipratropium bromide—Nasal congestion—Temozolomide—malignant glioma	0.00899	0.0158	CcSEcCtD
Ipratropium bromide—Thirst—Temozolomide—malignant glioma	0.00861	0.0151	CcSEcCtD
Ipratropium bromide—Dysphagia—Carmustine—malignant glioma	0.00733	0.0128	CcSEcCtD
Ipratropium bromide—Dysphagia—Temozolomide—malignant glioma	0.00708	0.0124	CcSEcCtD
Ipratropium bromide—Bronchitis—Temozolomide—malignant glioma	0.00681	0.0119	CcSEcCtD
Ipratropium bromide—Dysuria—Temozolomide—malignant glioma	0.00662	0.0116	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00658	0.0115	CcSEcCtD
Ipratropium bromide—Pollakiuria—Temozolomide—malignant glioma	0.00654	0.0115	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Carmustine—malignant glioma	0.0064	0.0112	CcSEcCtD
Ipratropium bromide—Stomatitis—Carmustine—malignant glioma	0.00637	0.0112	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Carmustine—malignant glioma	0.00635	0.0111	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Temozolomide—malignant glioma	0.00619	0.0108	CcSEcCtD
Ipratropium bromide—Stomatitis—Temozolomide—malignant glioma	0.00615	0.0108	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Temozolomide—malignant glioma	0.00614	0.0108	CcSEcCtD
Ipratropium bromide—Sinusitis—Temozolomide—malignant glioma	0.00592	0.0104	CcSEcCtD
Ipratropium bromide—Haemoglobin—Carmustine—malignant glioma	0.00589	0.0103	CcSEcCtD
Ipratropium bromide—Haemorrhage—Carmustine—malignant glioma	0.00586	0.0103	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Carmustine—malignant glioma	0.00583	0.0102	CcSEcCtD
Ipratropium bromide—Haemoglobin—Temozolomide—malignant glioma	0.0057	0.00999	CcSEcCtD
Ipratropium bromide—Haemorrhage—Temozolomide—malignant glioma	0.00567	0.00994	CcSEcCtD
Ipratropium bromide—Visual impairment—Carmustine—malignant glioma	0.00565	0.00991	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Temozolomide—malignant glioma	0.00564	0.00989	CcSEcCtD
Ipratropium bromide—Pharyngitis—Temozolomide—malignant glioma	0.00562	0.00986	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Temozolomide—malignant glioma	0.0056	0.00981	CcSEcCtD
Ipratropium bromide—Urethral disorder—Temozolomide—malignant glioma	0.00556	0.00974	CcSEcCtD
Ipratropium bromide—Eye disorder—Carmustine—malignant glioma	0.00548	0.00961	CcSEcCtD
Ipratropium bromide—Visual impairment—Temozolomide—malignant glioma	0.00546	0.00957	CcSEcCtD
Ipratropium bromide—Flushing—Carmustine—malignant glioma	0.00544	0.00954	CcSEcCtD
Ipratropium bromide—Eye disorder—Temozolomide—malignant glioma	0.0053	0.00928	CcSEcCtD
Ipratropium bromide—Tinnitus—Temozolomide—malignant glioma	0.00528	0.00926	CcSEcCtD
Ipratropium bromide—Flushing—Temozolomide—malignant glioma	0.00526	0.00922	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Temozolomide—malignant glioma	0.00526	0.00922	CcSEcCtD
Ipratropium bromide—Immune system disorder—Temozolomide—malignant glioma	0.00512	0.00897	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Temozolomide—malignant glioma	0.00511	0.00895	CcSEcCtD
Ipratropium bromide—Back pain—Carmustine—malignant glioma	0.00494	0.00866	CcSEcCtD
Ipratropium bromide—Dysgeusia—Temozolomide—malignant glioma	0.00483	0.00847	CcSEcCtD
Ipratropium bromide—Vision blurred—Carmustine—malignant glioma	0.00481	0.00843	CcSEcCtD
Ipratropium bromide—Tremor—Carmustine—malignant glioma	0.00478	0.00839	CcSEcCtD
Ipratropium bromide—Back pain—Temozolomide—malignant glioma	0.00477	0.00837	CcSEcCtD
Ipratropium bromide—Vision blurred—Temozolomide—malignant glioma	0.00465	0.00815	CcSEcCtD
Ipratropium bromide—Tremor—Temozolomide—malignant glioma	0.00462	0.0081	CcSEcCtD
Ipratropium bromide—Angioedema—Temozolomide—malignant glioma	0.00451	0.0079	CcSEcCtD
Ipratropium bromide—Hypertension—Carmustine—malignant glioma	0.00441	0.00773	CcSEcCtD
Ipratropium bromide—Palpitations—Temozolomide—malignant glioma	0.00436	0.00764	CcSEcCtD
Ipratropium bromide—Chest pain—Carmustine—malignant glioma	0.00435	0.00762	CcSEcCtD
Ipratropium bromide—Myalgia—Carmustine—malignant glioma	0.00435	0.00762	CcSEcCtD
Ipratropium bromide—Cough—Temozolomide—malignant glioma	0.0043	0.00755	CcSEcCtD
Ipratropium bromide—Hypertension—Temozolomide—malignant glioma	0.00426	0.00747	CcSEcCtD
Ipratropium bromide—Myalgia—Temozolomide—malignant glioma	0.0042	0.00736	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00417	0.00731	CcSEcCtD
Ipratropium bromide—Oedema—Carmustine—malignant glioma	0.00417	0.0073	CcSEcCtD
Ipratropium bromide—Infection—Carmustine—malignant glioma	0.00414	0.00726	CcSEcCtD
Ipratropium bromide—Dry mouth—Temozolomide—malignant glioma	0.00411	0.0072	CcSEcCtD
Ipratropium bromide—Tachycardia—Carmustine—malignant glioma	0.00407	0.00713	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Temozolomide—malignant glioma	0.00403	0.00706	CcSEcCtD
Ipratropium bromide—Oedema—Temozolomide—malignant glioma	0.00403	0.00706	CcSEcCtD
Ipratropium bromide—Infection—Temozolomide—malignant glioma	0.004	0.00701	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Temozolomide—malignant glioma	0.00395	0.00692	CcSEcCtD
Ipratropium bromide—Skin disorder—Temozolomide—malignant glioma	0.00391	0.00686	CcSEcCtD
Ipratropium bromide—Hypotension—Carmustine—malignant glioma	0.00389	0.00683	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Temozolomide—malignant glioma	0.00389	0.00682	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.0038	0.00665	CcSEcCtD
Ipratropium bromide—Insomnia—Carmustine—malignant glioma	0.00377	0.00661	CcSEcCtD
Ipratropium bromide—Paraesthesia—Carmustine—malignant glioma	0.00374	0.00656	CcSEcCtD
Ipratropium bromide—Dyspnoea—Carmustine—malignant glioma	0.00371	0.00651	CcSEcCtD
Ipratropium bromide—Somnolence—Carmustine—malignant glioma	0.0037	0.00649	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00367	0.00643	CcSEcCtD
Ipratropium bromide—Insomnia—Temozolomide—malignant glioma	0.00364	0.00638	CcSEcCtD
Ipratropium bromide—Paraesthesia—Temozolomide—malignant glioma	0.00362	0.00634	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Carmustine—malignant glioma	0.0036	0.00631	CcSEcCtD
Ipratropium bromide—Dyspnoea—Temozolomide—malignant glioma	0.00359	0.00629	CcSEcCtD
Ipratropium bromide—Somnolence—Temozolomide—malignant glioma	0.00358	0.00628	CcSEcCtD
Ipratropium bromide—Constipation—Carmustine—malignant glioma	0.00356	0.00625	CcSEcCtD
Ipratropium bromide—Pain—Carmustine—malignant glioma	0.00356	0.00625	CcSEcCtD
Ipratropium bromide—Dyspepsia—Temozolomide—malignant glioma	0.00354	0.00621	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00348	0.00609	CcSEcCtD
Ipratropium bromide—Fatigue—Temozolomide—malignant glioma	0.00347	0.00609	CcSEcCtD
Ipratropium bromide—Pain—Temozolomide—malignant glioma	0.00344	0.00604	CcSEcCtD
Ipratropium bromide—Constipation—Temozolomide—malignant glioma	0.00344	0.00604	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Carmustine—malignant glioma	0.00341	0.00597	CcSEcCtD
Ipratropium bromide—Abdominal pain—Carmustine—malignant glioma	0.00329	0.00577	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Temozolomide—malignant glioma	0.00329	0.00577	CcSEcCtD
Ipratropium bromide—Urticaria—Temozolomide—malignant glioma	0.0032	0.00561	CcSEcCtD
Ipratropium bromide—Abdominal pain—Temozolomide—malignant glioma	0.00318	0.00558	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Carmustine—malignant glioma	0.00307	0.00538	CcSEcCtD
Ipratropium bromide—Asthenia—Carmustine—malignant glioma	0.00299	0.00524	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Temozolomide—malignant glioma	0.00297	0.0052	CcSEcCtD
Ipratropium bromide—Asthenia—Temozolomide—malignant glioma	0.00289	0.00506	CcSEcCtD
Ipratropium bromide—Diarrhoea—Carmustine—malignant glioma	0.00285	0.005	CcSEcCtD
Ipratropium bromide—Pruritus—Temozolomide—malignant glioma	0.00285	0.00499	CcSEcCtD
Ipratropium bromide—Dizziness—Carmustine—malignant glioma	0.00276	0.00483	CcSEcCtD
Ipratropium bromide—Diarrhoea—Temozolomide—malignant glioma	0.00275	0.00483	CcSEcCtD
Ipratropium bromide—Dizziness—Temozolomide—malignant glioma	0.00266	0.00467	CcSEcCtD
Ipratropium bromide—Vomiting—Carmustine—malignant glioma	0.00265	0.00464	CcSEcCtD
Ipratropium bromide—Rash—Carmustine—malignant glioma	0.00263	0.00461	CcSEcCtD
Ipratropium bromide—Dermatitis—Carmustine—malignant glioma	0.00262	0.0046	CcSEcCtD
Ipratropium bromide—Headache—Carmustine—malignant glioma	0.00261	0.00458	CcSEcCtD
Ipratropium bromide—Vomiting—Temozolomide—malignant glioma	0.00256	0.00449	CcSEcCtD
Ipratropium bromide—Rash—Temozolomide—malignant glioma	0.00254	0.00445	CcSEcCtD
Ipratropium bromide—Dermatitis—Temozolomide—malignant glioma	0.00254	0.00445	CcSEcCtD
Ipratropium bromide—Headache—Temozolomide—malignant glioma	0.00252	0.00442	CcSEcCtD
Ipratropium bromide—Nausea—Carmustine—malignant glioma	0.00247	0.00434	CcSEcCtD
Ipratropium bromide—Nausea—Temozolomide—malignant glioma	0.00239	0.00419	CcSEcCtD
Ipratropium bromide—CHRM5—Signaling Pathways—FN1—malignant glioma	6.81e-05	0.000319	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—F2—malignant glioma	6.81e-05	0.000319	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PIK3CD—malignant glioma	6.8e-05	0.000319	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PIK3CD—malignant glioma	6.74e-05	0.000316	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—BAD—malignant glioma	6.73e-05	0.000315	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NOTCH1—malignant glioma	6.66e-05	0.000312	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MMP3—malignant glioma	6.57e-05	0.000308	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—PIK3CB—malignant glioma	6.55e-05	0.000307	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MMP3—malignant glioma	6.55e-05	0.000307	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—PIK3CB—malignant glioma	6.53e-05	0.000306	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CD80—malignant glioma	6.53e-05	0.000306	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PIK3CG—malignant glioma	6.51e-05	0.000305	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—APC—malignant glioma	6.51e-05	0.000305	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CDKN2B—malignant glioma	6.51e-05	0.000305	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CDKN2B—malignant glioma	6.49e-05	0.000304	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MMP3—malignant glioma	6.49e-05	0.000304	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PTGS1—malignant glioma	6.48e-05	0.000304	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—PIK3CB—malignant glioma	6.47e-05	0.000303	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP2B6—malignant glioma	6.44e-05	0.000302	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—EGF—malignant glioma	6.44e-05	0.000302	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CDKN2B—malignant glioma	6.43e-05	0.000301	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PTPN11—malignant glioma	6.4e-05	0.0003	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PTK2—malignant glioma	6.32e-05	0.000296	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PTK2—malignant glioma	6.3e-05	0.000296	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—CXCL8—malignant glioma	6.3e-05	0.000295	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CXCL8—malignant glioma	6.28e-05	0.000294	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PTK2—malignant glioma	6.24e-05	0.000293	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CXCL8—malignant glioma	6.21e-05	0.000291	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HES1—malignant glioma	6.21e-05	0.000291	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HES1—malignant glioma	6.19e-05	0.00029	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NCOR1—malignant glioma	6.18e-05	0.00029	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NCOR1—malignant glioma	6.16e-05	0.000289	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HES1—malignant glioma	6.13e-05	0.000287	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—BRAF—malignant glioma	6.12e-05	0.000287	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NCOR1—malignant glioma	6.1e-05	0.000286	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—RAF1—malignant glioma	6.09e-05	0.000286	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—RAF1—malignant glioma	6.07e-05	0.000285	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—BCHE—malignant glioma	6.02e-05	0.000282	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—IL2—malignant glioma	6.02e-05	0.000282	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—RAF1—malignant glioma	6.02e-05	0.000282	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CAV1—malignant glioma	6e-05	0.000281	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—IL2—malignant glioma	6e-05	0.000281	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—AKT2—malignant glioma	5.96e-05	0.000279	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PIK3CB—malignant glioma	5.95e-05	0.000279	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SLC5A5—malignant glioma	5.95e-05	0.000279	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—IL2—malignant glioma	5.94e-05	0.000278	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—EGFR—malignant glioma	5.93e-05	0.000278	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PIK3CB—malignant glioma	5.93e-05	0.000278	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PDGFRA—malignant glioma	5.92e-05	0.000277	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PDGFRA—malignant glioma	5.9e-05	0.000276	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—IDH1—malignant glioma	5.89e-05	0.000276	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	5.87e-05	0.000275	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	5.84e-05	0.000274	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SPP1—malignant glioma	5.74e-05	0.000269	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PIK3CD—malignant glioma	5.73e-05	0.000268	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SPP1—malignant glioma	5.72e-05	0.000268	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CXCL8—malignant glioma	5.72e-05	0.000268	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SPHK1—malignant glioma	5.7e-05	0.000267	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CXCL8—malignant glioma	5.7e-05	0.000267	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—PIK3CA—malignant glioma	5.67e-05	0.000266	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SPP1—malignant glioma	5.67e-05	0.000266	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	5.64e-05	0.000265	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—KRAS—malignant glioma	5.61e-05	0.000263	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP2C18—malignant glioma	5.59e-05	0.000262	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—FGF2—malignant glioma	5.48e-05	0.000257	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3CG—malignant glioma	5.47e-05	0.000256	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL2—malignant glioma	5.46e-05	0.000256	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL2—malignant glioma	5.45e-05	0.000255	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TERT—malignant glioma	5.44e-05	0.000255	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TERT—malignant glioma	5.43e-05	0.000254	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL2—malignant glioma	5.39e-05	0.000253	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TERT—malignant glioma	5.37e-05	0.000252	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PDGFB—malignant glioma	5.31e-05	0.000249	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PDGFB—malignant glioma	5.3e-05	0.000248	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FGFR1—malignant glioma	5.29e-05	0.000248	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PPARG—malignant glioma	5.28e-05	0.000247	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FGFR1—malignant glioma	5.27e-05	0.000247	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PDGFB—malignant glioma	5.25e-05	0.000246	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FGFR1—malignant glioma	5.22e-05	0.000245	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HIF1A—malignant glioma	5.21e-05	0.000244	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HIF1A—malignant glioma	5.19e-05	0.000243	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—PIK3CA—malignant glioma	5.15e-05	0.000241	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HIF1A—malignant glioma	5.14e-05	0.000241	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MDM2—malignant glioma	5.13e-05	0.00024	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—RAF1—malignant glioma	5.11e-05	0.00024	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ERBB2—malignant glioma	5.06e-05	0.000237	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CAV1—malignant glioma	5.04e-05	0.000236	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CAV1—malignant glioma	5.02e-05	0.000235	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PIK3CB—malignant glioma	4.99e-05	0.000234	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—KDR—malignant glioma	4.98e-05	0.000233	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CAV1—malignant glioma	4.97e-05	0.000233	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—KDR—malignant glioma	4.96e-05	0.000233	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—KDR—malignant glioma	4.91e-05	0.00023	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3CD—malignant glioma	4.81e-05	0.000225	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CXCL8—malignant glioma	4.8e-05	0.000225	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FN1—malignant glioma	4.79e-05	0.000225	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—F2—malignant glioma	4.79e-05	0.000225	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTP1—malignant glioma	4.79e-05	0.000225	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FN1—malignant glioma	4.78e-05	0.000224	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—F2—malignant glioma	4.78e-05	0.000224	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—BAD—malignant glioma	4.74e-05	0.000222	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—F2—malignant glioma	4.73e-05	0.000222	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FN1—malignant glioma	4.73e-05	0.000222	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—BAD—malignant glioma	4.72e-05	0.000221	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NOTCH1—malignant glioma	4.69e-05	0.00022	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NOTCH1—malignant glioma	4.68e-05	0.000219	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—BAD—malignant glioma	4.67e-05	0.000219	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CAT—malignant glioma	4.66e-05	0.000219	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—AKT1—malignant glioma	4.63e-05	0.000217	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	4.63e-05	0.000217	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CD80—malignant glioma	4.59e-05	0.000215	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CASP3—malignant glioma	4.59e-05	0.000215	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3CG—malignant glioma	4.59e-05	0.000215	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—APC—malignant glioma	4.59e-05	0.000215	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL2—malignant glioma	4.58e-05	0.000215	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CD80—malignant glioma	4.58e-05	0.000215	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—APC—malignant glioma	4.57e-05	0.000214	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3CG—malignant glioma	4.57e-05	0.000214	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CD80—malignant glioma	4.54e-05	0.000213	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—EGF—malignant glioma	4.53e-05	0.000213	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	4.53e-05	0.000212	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—APC—malignant glioma	4.53e-05	0.000212	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTT1—malignant glioma	4.52e-05	0.000212	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—EGF—malignant glioma	4.52e-05	0.000212	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PTPN11—malignant glioma	4.51e-05	0.000211	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PTPN11—malignant glioma	4.49e-05	0.000211	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—EGF—malignant glioma	4.48e-05	0.00021	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PTPN11—malignant glioma	4.45e-05	0.000209	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—NCOR1—malignant glioma	4.4e-05	0.000206	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MMP9—malignant glioma	4.34e-05	0.000203	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PTEN—malignant glioma	4.31e-05	0.000202	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—BRAF—malignant glioma	4.31e-05	0.000202	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—BRAF—malignant glioma	4.3e-05	0.000201	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—BRAF—malignant glioma	4.26e-05	0.0002	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PTGS1—malignant glioma	4.23e-05	0.000199	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—AKT1—malignant glioma	4.21e-05	0.000197	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AKT2—malignant glioma	4.2e-05	0.000197	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3CB—malignant glioma	4.19e-05	0.000196	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AKT2—malignant glioma	4.18e-05	0.000196	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—EGFR—malignant glioma	4.18e-05	0.000196	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—EGFR—malignant glioma	4.17e-05	0.000195	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PTGS2—malignant glioma	4.15e-05	0.000195	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AKT2—malignant glioma	4.14e-05	0.000194	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—EGFR—malignant glioma	4.12e-05	0.000193	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3CD—malignant glioma	4.03e-05	0.000189	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3CD—malignant glioma	4.02e-05	0.000188	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—PIK3CA—malignant glioma	3.99e-05	0.000187	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—PIK3CA—malignant glioma	3.98e-05	0.000187	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	3.98e-05	0.000187	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—KRAS—malignant glioma	3.95e-05	0.000185	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	3.94e-05	0.000185	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—BCHE—malignant glioma	3.94e-05	0.000185	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—KRAS—malignant glioma	3.93e-05	0.000184	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—KRAS—malignant glioma	3.9e-05	0.000183	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—VEGFA—malignant glioma	3.9e-05	0.000183	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.89e-05	0.000182	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FGF2—malignant glioma	3.86e-05	0.000181	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—STAT3—malignant glioma	3.86e-05	0.000181	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FGF2—malignant glioma	3.85e-05	0.00018	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FGF2—malignant glioma	3.81e-05	0.000179	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	3.63e-05	0.00017	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PTEN—malignant glioma	3.62e-05	0.00017	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PIK3CA—malignant glioma	3.62e-05	0.000169	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MDM2—malignant glioma	3.61e-05	0.000169	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MDM2—malignant glioma	3.6e-05	0.000169	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RAF1—malignant glioma	3.6e-05	0.000169	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CAV1—malignant glioma	3.59e-05	0.000168	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RAF1—malignant glioma	3.59e-05	0.000168	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MYC—malignant glioma	3.58e-05	0.000168	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	3.58e-05	0.000168	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MDM2—malignant glioma	3.57e-05	0.000167	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ERBB2—malignant glioma	3.56e-05	0.000167	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RAF1—malignant glioma	3.55e-05	0.000167	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ERBB2—malignant glioma	3.55e-05	0.000166	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ERBB2—malignant glioma	3.52e-05	0.000165	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	3.51e-05	0.000165	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—EGFR—malignant glioma	3.51e-05	0.000164	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3CB—malignant glioma	3.5e-05	0.000164	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	3.47e-05	0.000163	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CXCL8—malignant glioma	3.38e-05	0.000158	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CXCL8—malignant glioma	3.37e-05	0.000158	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CXCL8—malignant glioma	3.33e-05	0.000156	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—KRAS—malignant glioma	3.31e-05	0.000155	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.27e-05	0.000153	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	3.26e-05	0.000153	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	3.25e-05	0.000152	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CASP3—malignant glioma	3.23e-05	0.000152	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL2—malignant glioma	3.23e-05	0.000151	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CASP3—malignant glioma	3.22e-05	0.000151	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	3.22e-05	0.000151	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL2—malignant glioma	3.22e-05	0.000151	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CASP3—malignant glioma	3.19e-05	0.00015	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL2—malignant glioma	3.19e-05	0.000149	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PPARG—malignant glioma	3.16e-05	0.000148	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTP1—malignant glioma	3.13e-05	0.000147	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MMP9—malignant glioma	3.05e-05	0.000143	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CAT—malignant glioma	3.05e-05	0.000143	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MMP9—malignant glioma	3.04e-05	0.000143	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PIK3CA—malignant glioma	3.04e-05	0.000143	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PTEN—malignant glioma	3.04e-05	0.000142	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PTEN—malignant glioma	3.03e-05	0.000142	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MMP9—malignant glioma	3.02e-05	0.000141	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PTEN—malignant glioma	3e-05	0.000141	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—AKT1—malignant glioma	2.96e-05	0.000139	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—AKT1—malignant glioma	2.95e-05	0.000138	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TP53—malignant glioma	2.94e-05	0.000138	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—AKT1—malignant glioma	2.92e-05	0.000137	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NCOR1—malignant glioma	2.88e-05	0.000135	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.87e-05	0.000135	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—VEGFA—malignant glioma	2.74e-05	0.000129	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—VEGFA—malignant glioma	2.73e-05	0.000128	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—STAT3—malignant glioma	2.72e-05	0.000127	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—VEGFA—malignant glioma	2.71e-05	0.000127	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—STAT3—malignant glioma	2.71e-05	0.000127	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—STAT3—malignant glioma	2.68e-05	0.000126	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3CA—malignant glioma	2.55e-05	0.00012	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MYC—malignant glioma	2.52e-05	0.000118	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MYC—malignant glioma	2.52e-05	0.000118	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.51e-05	0.000117	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MYC—malignant glioma	2.49e-05	0.000117	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—AKT1—malignant glioma	2.49e-05	0.000117	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PTGS2—malignant glioma	2.48e-05	0.000116	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—EGFR—malignant glioma	2.47e-05	0.000116	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—EGFR—malignant glioma	2.46e-05	0.000115	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—EGFR—malignant glioma	2.44e-05	0.000114	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CAV1—malignant glioma	2.35e-05	0.00011	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—KRAS—malignant glioma	2.33e-05	0.000109	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—KRAS—malignant glioma	2.32e-05	0.000109	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—KRAS—malignant glioma	2.3e-05	0.000108	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PTEN—malignant glioma	2.16e-05	0.000101	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	2.14e-05	0.0001	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.14e-05	0.0001	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	2.14e-05	0.0001	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	2.11e-05	9.91e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—AKT1—malignant glioma	2.09e-05	9.78e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TP53—malignant glioma	2.07e-05	9.72e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TP53—malignant glioma	2.07e-05	9.69e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PPARG—malignant glioma	2.06e-05	9.67e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TP53—malignant glioma	2.05e-05	9.59e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.88e-05	8.81e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AKT1—malignant glioma	1.75e-05	8.2e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AKT1—malignant glioma	1.74e-05	8.18e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AKT1—malignant glioma	1.73e-05	8.1e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.64e-05	7.68e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PTGS2—malignant glioma	1.62e-05	7.61e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.53e-05	7.16e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PTEN—malignant glioma	1.42e-05	6.63e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—AKT1—malignant glioma	1.25e-05	5.85e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3CA—malignant glioma	9.98e-06	4.68e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AKT1—malignant glioma	8.16e-06	3.82e-05	CbGpPWpGaD
